Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Conditions

• Cardiotoxicity

Interventions

• DRUG: Empagliflozin 10 MG
• OTHER: Placebo

Sponsor

Maria Sklodowska-Curie National Research Institute of Oncology

Collaborators

• [object Object]